Calea and Fresenius Kabi hosted a European Society for Clinical Nutrition and Metabolism (ESPEN) Life Long Learning (LLL) course on Nutritional Support in Cancer at the British Association for Parenteral and Enteral Nutrition (BAPEN) conference, in Birmingham in November.

lll-1The experience and internationally renowned speakers Dr Alessandro Laviano, Dr Jon Shaffer and Prof Alastair Forbes presented theories, data and case reports to healthcare professionals from the UK.

The course covered mechanisms of cancer cachexia, nutritional effects on cancer therapy, benefits and limitations of nutritional support and pharmacological and multi-modal therapy for cancer cachexia.

The course was followed with a talk from Dr Sorrel Burden, Clinical Senior Lecturer at The University of Manchester. She presented new data about patient reported outcomes of people on home parenteral nutrition (HPN).

The Life Long Learning (LLL) programme in Clinical Nutrition and Metabolism is an innovative and effective educational programme for medical doctors and health specialists offering training on-line and at live courses, by a variety of modern training methodologies and resources.

LLL programme in Clinical Nutrition and Metabolism is based on an Educational Curriculum offering 120 training modules created and peer reviewed by recognized experts in the field.

Charlene Leak, Senior Product Manager for Calea; ‘It was a privilege to be part of the excellent educational programme. All of the feedback from the attendees was excellent and we look forward to further supporting ESPEN with their Life Long Learning Educational Programme in the UK.’

Prof Alastair Forbes “It was great to be involved in such a stimulating interactive session and to see again the practical nature of the ESPEN Llll2 LL material.  Much more of course is available via the Society’s website at www.espen.org or directly through lllnutrition.com.  Thanks to Calea, Fresenius Kabi and BAPEN for making it possible on this occasion.”

Print Friendly, PDF & Email
HPN Homecare team call: 0800 121 8300
Biosimilars Homecare team call: 0800 090 2461